A genetic disease that results in the formation of thick
mucus in the airways, cystic fibrosis (CF) causes patients to
experience severe difficulty with digestive and respiratory
functions. Some 70,000 people worldwide suffer from cystic
fibrosis, and millions unknowingly carry the defective CF
gene.
Duke continues to advance the diagnosis and treatment of
cystic fibrosis, and has contributed to the marked improvement
in the quality and quantity of life for patients in recent
years.
Certified by the Cystic Fibrosis Foundation, the Duke Cystic
Fibrosis Clinic cares for both inpatients and outpatients
suffering from every degree of CF.
We are staffed by a multidisciplinary team that includes
pulmonologists and critical care specialists, nurse
practitioners, respiratory therapists, nutritionists, social
workers, and a pharmacist.
Duke's internationally recognized lung transplantation program has
been highly successful in treating CF patients, particularly
those with antibiotic-resistant lung infections. We partner
with pharmaceutical companies and other institutions to develop
combinations of existing and experimental drugs to treat
infections and prevent them from affecting the transplanted
lungs.
In addition, our clinicians work closely with Duke
researchers in an effort to better understand, treat, and
eventually cure CF. Improvements in antibiotics, drug-delivery
systems, and pulmonary rehabilitation, as well as recent
strides in genetic technology, show great promise for cystic
fibrosis patients and those who carry the CF gene.
To learn more about the Duke Cystic Fibrosis Clinic, or to
schedule an appointment or get a referral, call
919-668-7630 locally or 888-ASK-DUKE
(888-275-3853) toll-free.
Physicians
Physicians offering this service include:
Locations
This service is available at:
